philipp geyer, ph.d. of omicera on high-throughput clinical proteomics and applications to covid-19
Published 3 years ago • 509 plays • Length 14:41Download video MP4
Download video MP3
Similar videos
-
48:28
high throughput proteomics during a pandemic, immune suppression in the early stage of covid-19
-
14:54
seer at bruker exceed 2021: plasma proteomics with the proteograph™ product suite and timstof
-
13:00
streamlined & automated sample processing workflows for in-depth proteomic analyses by preomics
-
5:15
dr. david persing: how hospitals can use cepheid's covid-19 test in patient management
-
4:11
covid-19 and ip protections on critical medical innovations
-
23:25
pocus for covid19
-
4:53
philips azurion - introducing the next generation interventional solution
-
11:06
philips at euroecho 2021 - professor teresa lopez
-
14:56
processing timstof pro proteomics data with the latest generation of biognosys software
-
59:16
covid-19 and the immune response with dr. donna farber
-
21:58
wearable device to monitor covid-19 symptoms with john a. rogers, phd
-
1:30:54
genworks relevance of pft in covid 19 era
-
1:04:29
level up immune profiling of the tumor microenvironment - deep phenotyping and target discovery
-
57:19
fci webinar - the impact of covid-19 on digital health in australian primary care
-
0:55
patient success story in the office-based lab (obl) with dr. gerald niedzwiecki
-
13:05
the impact of covid-19 on immunocompromised patients
-
16:23
anti-covid therapies - new research and mechanisms of action
-
1:12:49
pff response to covid-19: the current landscape
-
44:43
virtual pub with peter horvath
-
2:27
covid-19 testing
-
10:35
introduction to autoantibody seromics, huprot™ proteome microarray and phip-seq antibody profiling